Immunohistochemistry in Anaplastic Lymphoma Kinase and Proto-Oncogene Tyrosine-Protein Kinase ROS

被引:3
|
作者
Mino-Kenudson, Mari [1 ,2 ]
机构
[1] Massachusetts Gen Hosp, Dept Pathol, 55 Fruit St,Warren 122, Boston, MA 02114 USA
[2] Harvard Med Sch, Boston, MA USA
关键词
MOLECULAR TESTING GUIDELINE; LUNG-CANCER PATIENTS; ALK REARRANGEMENT; INHIBITORS; SELECTION;
D O I
10.5858/arpa.2018-0066-ED
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
引用
收藏
页码:792 / 793
页数:2
相关论文
共 50 条
  • [31] Point mutation in the exon 12 of tyrosine kinase proto-oncogene of Ondine-Hirschsprung syndrome.
    Sakai, T
    Wakizaka, A
    Nirasawa, Y
    Itoh, Y
    Kurosawa, S
    Nagashima, Y
    Tobe, M
    FASEB JOURNAL, 1997, 11 (09): : A947 - A947
  • [32] IBRUTINIB Inhibitor of Tyrosine-Protein Kinase BTK Oncolytic
    Andritsos, L. A.
    Jaglowski, S. M.
    DRUGS OF THE FUTURE, 2013, 38 (06) : 359 - 366
  • [33] Therapeutic potential of tyrosine-protein kinase MET in osteosarcoma
    Zeng, Ming
    Liu, Can
    Gong, Haoli
    Tang, Zhongwen
    Wen, Jie
    Wang, Sisi
    Xiao, Sheng
    FRONTIERS IN MOLECULAR BIOSCIENCES, 2024, 11
  • [34] The Epidermal Growth Factor, Anaplastic Lymphoma Kinase, and ROS Proto-oncogene 1 Mutation Profile of Non-Small Cell Lung Carcinomas in the Turkish Population: A Single-Center Analysis
    Gun, Eylul
    Cakir, Izzetiye Ebru
    Ersoz, Hasan
    Oflazoglu, Utku
    Sertogullarindan, Bunyamin
    THORACIC RESEARCH AND PRACTICE, 2024, 25 (03) : 102 - 109
  • [35] Point mutation in exon 12 of the receptor tyrosine kinase proto-oncogene RET in Ondine-Hirschsprung syndrome
    Sakai, T
    Wakizaka, A
    Matsuda, H
    Nirasawa, Y
    Itoh, Y
    PEDIATRICS, 1998, 101 (05) : 924 - 926
  • [36] The proto-oncogene tyrosine kinase c-SRC facilitates glioblastoma progression by remodeling fatty acid synthesis
    Zhao, Wentao
    Ouyang, Cong
    Zhang, Liang
    Wang, Jinyang
    Zhang, Jiaojiao
    Zhang, Yan
    Huang, Chen
    Xiao, Qiao
    Jiang, Bin
    Lin, Furong
    Zhang, Cixiong
    Zhu, Mingxia
    Xie, Changchuan
    Huang, Xi
    Zhang, Bingchang
    Zhao, Wenpeng
    He, Jiawei
    Chen, Sifang
    Liu, Xiyao
    Lin, Donghai
    Li, Qinxi
    Wang, Zhanxiang
    NATURE COMMUNICATIONS, 2024, 15 (01)
  • [37] Cytosolic tubulin associates with the Cbl and Vav proto-oncogene products and the Syk tyrosine kinase in B cells.
    Fernandez, JA
    Peters, JD
    Keshvara, LM
    Harrison, ML
    Geahlen, RL
    FASEB JOURNAL, 1997, 11 (09): : A1055 - A1055
  • [38] Evaluation of the absolute oral bioavailability of the anaplastic lymphoma kinase/c-ROS oncogene 1 kinase inhibitor lorlatinib in healthy participants
    Jennifer E. Hibma
    Melissa O’Gorman
    Sunil Nepal
    Sylvester Pawlak
    Katherine Ginman
    Yazdi K. Pithavala
    Cancer Chemotherapy and Pharmacology, 2022, 89 : 71 - 81
  • [39] Evaluation of the absolute oral bioavailability of the anaplastic lymphoma kinase/c-ROS oncogene 1 kinase inhibitor lorlatinib in healthy participants
    Hibma, Jennifer E.
    O'Gorman, Melissa
    Nepal, Sunil
    Pawlak, Sylvester
    Ginman, Katherine
    Pithavala, Yazdi K.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2022, 89 (01) : 71 - 81
  • [40] Transcriptional repression of the RET proto-oncogene by a mitogen activated protein kinase-dependent signalling pathway
    Andrew, SD
    Capes-Davis, A
    Delhanty, PJD
    Marsh, DJ
    Mulligan, LM
    Robinson, BG
    GENE, 2002, 298 (01) : 9 - 19